• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Moberg Pharma’s Nomination Committee Appointed

    Chelsea Pratt
    Nov. 04, 2016 01:06AM PST
    Life Science Investing News

    In accordance with the resolution of the Annual General Meeting on May 18, 2016, the Chairman of the Board has contacted the company’s three largest shareholders or group of shareholders in terms of votes to form a Nomination Committee.

    Moberg Pharma AB (STO:MOB) In accordance with the resolution of the Annual General Meeting on May 18, 2016, the Chairman of the Board has contacted the company’s three largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee. As not all of the company’s three largest shareholders or group of shareholders have wished to appoint such representative, the forth largest shareholder/group of shareholders have been invited to appoint one representative and so on until the Nomination Committee now comprises of four members, in accordance with the resolution of the Annual General Meeting on May 18.
    Moberg Pharma’s Nomination Committee ahead of the 2017 Annual General
    Meeting comprises:
    · Thomas Eklund, Chairman of the Board
    · Gillis Cullin, appointed by Östersjöstiftelsen
    · Anders Rodebjer, appointed by Wolco Invest
    · Helen Fasth Gillstedt, appointed by Handelsbanken Fonder
    Together, the Nomination Committee represents 22.6 percent of the shares
    in Moberg Pharma as of September 30, 2016.
    The Nomination Committee shall submit proposals for resolution by the
    2017 Annual General Meeting pertaining to the election of Chairman of
    the Board, fees and composition of the Board, auditors’ fees and the
    election of auditors.
    The 2017 Annual General Meeting will be held in Stockholm on May 16.
    Shareholders wishing to submit proposals to Moberg Pharma’s Nomination
    Committee can do so by e-mail to info@mobergpharma.se
    by 31 December 2016.
    About this information
    This information is information that Moberg Pharma AB is obliged to make
    public pursuant to the EU Market Abuse Regulation. The information was
    submitted for publication, through the agency of the contact person set
    out above, at 8.30 a.m. CET on November 4th, 2016.
    About Moberg Pharma, www.mobergpharma.com
    Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical
    company with OTC sales operations in the U.S. and a distributor network
    in more than 40 countries. The company’s portfolio includes the OTC
    brands Kerasal®, Kerasal Nail®, Balmex®, NewSkin®, Domeboro®, Fiber
    Choice®and PediaCare®. Kerasal Nail® (Emtrix® or Nalox™ in certain
    markets) is a leading OTC treatment of nail disorders in the U.S.,
    Canada as well as in several markets in EU and Southeast Asia. The
    company is growing organically as well as through acquisitions. Internal
    development programs focuses on innovative drug delivery of proven
    compounds and include two clinical stage assets, MOB-015 (onychomycosis)
    and BUPI (pain management in oral mucositis). Moberg Pharma has offices
    in Stockholm and New Jersey and the company’s shares are listed on the
    Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm (MOB.ST).
    This information was brought to you by Cision https://news.cision.com

    onychomycosiscanadaoral mucositisnomination committeemoberg pharma
    The Conversation (0)

    Go Deeper

    AI Powered
    Large pharmaceutical pill with gold dollar sign in the middle. Stock tickers and charts in the background.

    Top 5 Small-cap Pharma Stocks of 2025

    Medicine capsule showing active ingredients.

    5 Biggest Pharma Stocks

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×